|
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
1.188e-119 |
1.00
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
1.019e-105 |
1.00
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
4.452e-102 |
1.00
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
6.615e-147 |
0.56
|
| DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
1.395e-122 |
0.51
|
| 5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
8.746e-97 |
0.52
|
| ADRB1_PIG |
ADRB1 |
Beta-1 adrenergic receptor |
6.453e-96 |
0.38
|
| 5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
5.755e-92 |
0.51
|
| G3I1B6_CRIGR |
|
5-hydroxytryptamine receptor |
2.676e-82 |
0.32
|
| 5HT1B_CRIGR |
HTR1B |
5-hydroxytryptamine receptor 1B |
2.64e-81 |
0.32
|
| AP2S1_RAT |
Ap2s1 |
AP-2 complex subunit sigma |
7.389e-76 |
0.32
|
| 5HT7R_RAT |
Htr7 |
5-hydroxytryptamine receptor 7 |
3.142e-74 |
0.49
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
5.251e-74 |
0.56
|
| GTR3_HUMAN |
SLC2A3 |
Solute carrier family 2, facilitated glucose transporter member 3 |
1.373e-73 |
0.33
|
| Q9TSW7_PIG |
ADRA1A |
Alpha-1A adrenergic receptor |
7.44e-73 |
0.34
|
| GTR2_HUMAN |
SLC2A2 |
Solute carrier family 2, facilitated glucose transporter member 2 |
1.341e-72 |
0.33
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
4.336e-71 |
0.53
|
| ADA1A_RABIT |
ADRA1A |
Alpha-1A adrenergic receptor |
7.924e-61 |
0.40
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
7.313e-59 |
0.54
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
4.396e-55 |
0.49
|
| FABP7_HUMAN |
FABP7 |
Fatty acid-binding protein, brain |
1.104e-54 |
0.30
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
2.495e-54 |
0.54
|
| 5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
2.352e-51 |
0.53
|
| ADA1D_RAT |
Adra1d |
Alpha-1D adrenergic receptor |
1.459e-48 |
0.48
|
| ADA1A_RAT |
Adra1a |
Alpha-1A adrenergic receptor |
1.265e-46 |
0.48
|
| VDAC2_HUMAN |
VDAC2 |
Voltage-dependent anion-selective channel protein 2 |
2.276e-38 |
0.30
|
| DCPS_MOUSE |
Dcps |
m7GpppX diphosphatase |
4.454e-38 |
0.35
|
| 5HT1B_RAT |
Htr1b |
5-hydroxytryptamine receptor 1B |
2.268e-36 |
0.53
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
1.839e-34 |
0.48
|
| ADA1A_BOVIN |
ADRA1A |
Alpha-1A adrenergic receptor |
5.275e-34 |
0.36
|
| 5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
7.211e-34 |
0.44
|
| DCPS_HUMAN |
DCPS |
m7GpppX diphosphatase |
8.148e-33 |
0.35
|
| 5HT1B_HUMAN |
HTR1B |
5-hydroxytryptamine receptor 1B |
5.521e-31 |
0.42
|
| MDR1_HUMAN |
ABCB1 |
ATP-dependent translocase ABCB1 |
2.595e-30 |
0.39
|
| GNRHR_RAT |
Gnrhr |
Gonadotropin-releasing hormone receptor |
2.806e-28 |
0.36
|
| TAAR5_MOUSE |
Taar5 |
Trace amine-associated receptor 5 |
1.986e-27 |
0.34
|
| 5HT6R_MOUSE |
Htr6 |
5-hydroxytryptamine receptor 6 |
1.343e-26 |
0.33
|
| 5HT1D_HUMAN |
HTR1D |
5-hydroxytryptamine receptor 1D |
1.691e-26 |
0.42
|
| DRD3_RAT |
Drd3 |
D(3) dopamine receptor |
2.118e-26 |
0.37
|
| ADA2A_RAT |
Adra2a |
Alpha-2A adrenergic receptor |
3.317e-26 |
0.35
|
| DRD1_BOVIN |
DRD1 |
D(1A) dopamine receptor |
1.934e-25 |
0.42
|
| 5HT1D_MOUSE |
Htr1d |
5-hydroxytryptamine receptor 1D |
1.943e-24 |
0.32
|
| DRD1_HUMAN |
DRD1 |
D(1A) dopamine receptor |
5.854e-24 |
0.36
|
| GNRHR_HUMAN |
GNRHR |
Gonadotropin-releasing hormone receptor |
2.07e-23 |
0.36
|
| 5HT2A_BOVIN |
HTR2A |
5-hydroxytryptamine receptor 2A |
3.705e-23 |
0.33
|
| SC6A4_RAT |
Slc6a4 |
Sodium-dependent serotonin transporter |
4.749e-23 |
0.47
|
| GTR1_HUMAN |
SLC2A1 |
Solute carrier family 2, facilitated glucose transporter member 1 |
8.475e-23 |
0.38
|
| 5HT6R_HUMAN |
HTR6 |
5-hydroxytryptamine receptor 6 |
2.23e-22 |
0.46
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.516e-19 |
0.52
|
| ADRB2_CANLF |
ADRB2 |
Beta-2 adrenergic receptor |
7.094e-19 |
0.48
|
| 5HT2C_HUMAN |
HTR2C |
5-hydroxytryptamine receptor 2C |
1.763e-18 |
0.39
|
| HIF1A_HUMAN |
HIF1A |
Hypoxia-inducible factor 1-alpha |
3.527e-18 |
0.48
|
| NPBW1_HUMAN |
NPBWR1 |
Neuropeptides B/W receptor type 1 |
1.945e-17 |
0.37
|
| 5HT4R_CAVPO |
HTR4 |
5-hydroxytryptamine receptor 4 |
2.337e-17 |
0.37
|
| SC6A4_HUMAN |
SLC6A4 |
Sodium-dependent serotonin transporter |
2.552e-17 |
0.44
|
| NLRP1_HUMAN |
NLRP1 |
NACHT, LRR and PYD domains-containing protein 1 |
1.11e-16 |
0.37
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.11e-16 |
0.44
|
| CASP5_HUMAN |
CASP5 |
Caspase-5 |
2.22e-16 |
0.30
|
| DRD1_RAT |
Drd1 |
D(1A) dopamine receptor |
2.22e-16 |
0.40
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
2.22e-16 |
0.44
|
| K4JQ36_LAOST |
ace2 |
Carboxylic ester hydrolase |
2.22e-16 |
0.31
|
| SSR5_HUMAN |
SSTR5 |
Somatostatin receptor type 5 |
3.331e-16 |
0.31
|
| 5HT3B_RAT |
Htr3b |
5-hydroxytryptamine receptor 3B |
8.882e-16 |
0.44
|
| 5HT2B_RAT |
Htr2b |
5-hydroxytryptamine receptor 2B |
3.331e-15 |
0.37
|
| KCNB1_RAT |
Kcnb1 |
Potassium voltage-gated channel subfamily B member 1 |
4.441e-15 |
0.29
|
| NK1R_MOUSE |
Tacr1 |
Substance-P receptor |
4.441e-15 |
0.29
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
4.774e-15 |
0.41
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
6.772e-15 |
0.37
|
| 5HT3A_CAVPO |
HTR3A |
5-hydroxytryptamine receptor 3A |
1.099e-14 |
0.39
|
| DRD2_BOVIN |
DRD2 |
D(2) dopamine receptor |
1.599e-14 |
0.34
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
1.965e-14 |
0.52
|
| EBP_CAVPO |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
3.275e-14 |
0.33
|
| HRH2_HUMAN |
HRH2 |
Histamine H2 receptor |
8.638e-14 |
0.51
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
9.237e-14 |
0.38
|
| 5HT3A_RAT |
Htr3a |
5-hydroxytryptamine receptor 3A |
3.205e-13 |
0.44
|
| NTCP_HUMAN |
SLC10A1 |
Sodium/bile acid cotransporter |
4.263e-13 |
0.28
|
| Q9BJF5_TOXGO |
CDPK1 |
Calmodulin-domain protein kinase 1 |
7.291e-13 |
0.36
|
| CCR8_HUMAN |
CCR8 |
C-C chemokine receptor type 8 |
8.019e-13 |
0.30
|
| DRD5_HUMAN |
DRD5 |
D(1B) dopamine receptor |
8.411e-13 |
0.34
|
| ATP4A_PIG |
ATP4A |
Potassium-transporting ATPase alpha chain 1 |
1.406e-12 |
0.32
|
| FAAH1_HUMAN |
FAAH |
Fatty-acid amide hydrolase 1 |
3.126e-12 |
0.43
|
| 5HT5A_HUMAN |
HTR5A |
5-hydroxytryptamine receptor 5A |
9.97e-12 |
0.39
|
| Q7YWJ9_MUSDO |
Ache |
Carboxylic ester hydrolase |
1.187e-11 |
0.31
|
| Q9NJH6_NEPCI |
AO-AChE |
Ace-orthologous acetylcholinesterase |
1.187e-11 |
0.31
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
3.703e-11 |
0.40
|
| NTR1_HUMAN |
NTSR1 |
Neurotensin receptor type 1 |
5.196e-11 |
0.44
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
1.161e-10 |
0.51
|
| CASP4_HUMAN |
CASP4 |
Caspase-4 |
8.706e-10 |
0.30
|
| HS90B_HUMAN |
HSP90AB1 |
Heat shock protein HSP 90-beta |
9.18e-10 |
0.34
|
| KCNJ2_MOUSE |
Kcnj2 |
Inward rectifier potassium channel 2 |
1.45e-09 |
0.32
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
2.102e-09 |
0.37
|
| DRD4_RAT |
Drd4 |
D(4) dopamine receptor |
2.388e-09 |
0.40
|
| 5HT4R_HUMAN |
HTR4 |
5-hydroxytryptamine receptor 4 |
4.476e-09 |
0.39
|
| 5HT5A_MOUSE |
Htr5a |
5-hydroxytryptamine receptor 5A |
5.649e-09 |
0.38
|
| ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
1.782e-08 |
0.38
|
| VMAT2_HUMAN |
SLC18A2 |
Synaptic vesicular amine transporter |
2.021e-08 |
0.31
|
| GYRB_MYCS2 |
gyrB |
DNA gyrase subunit B |
3.477e-08 |
0.35
|
| REV1_HUMAN |
REV1 |
DNA repair protein REV1 |
3.91e-08 |
0.30
|
| 5HT3A_HUMAN |
HTR3A |
5-hydroxytryptamine receptor 3A |
6.924e-08 |
0.36
|
| LPAR2_HUMAN |
LPAR2 |
Lysophosphatidic acid receptor 2 |
8.204e-08 |
0.35
|
| CAC1S_RAT |
Cacna1s |
Voltage-dependent L-type calcium channel subunit alpha-1S |
8.883e-08 |
0.30
|
| XCT_HUMAN |
SLC7A11 |
Cystine/glutamate transporter |
9.036e-08 |
0.30
|
| KCNH2_HUMAN |
KCNH2 |
Potassium voltage-gated channel subfamily H member 2 |
9.728e-08 |
0.37
|
| FABP5_HUMAN |
FABP5 |
Fatty acid-binding protein 5 |
1.589e-07 |
0.30
|
| O61059_LEIME |
LmGT2 |
Glucose transporter |
1.833e-07 |
0.38
|
| MC4R_HUMAN |
MC4R |
Melanocortin receptor 4 |
2.13e-07 |
0.42
|
| CPT1B_RAT |
Cpt1b |
Carnitine O-palmitoyltransferase 1, muscle isoform |
2.298e-07 |
0.31
|
| ILVB_ARATH |
ALS |
Acetolactate synthase, chloroplastic |
2.668e-07 |
0.31
|
| DRD2_CHLAE |
DRD2 |
D(2) dopamine receptor |
3.988e-07 |
0.40
|
| 5HT2C_RAT |
Htr2c |
5-hydroxytryptamine receptor 2C |
4.053e-07 |
0.45
|
| ACH10_RAT |
Chrna10 |
Neuronal acetylcholine receptor subunit alpha-10 |
4.111e-07 |
0.35
|
| FABI_BACSU |
fabI |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI |
4.905e-07 |
0.29
|
| GATA4_MOUSE |
Gata4 |
Transcription factor GATA-4 |
6.148e-07 |
0.28
|
| NKX25_MOUSE |
Nkx2-5 |
Homeobox protein Nkx-2.5 |
6.148e-07 |
0.28
|
| IP3KB_HUMAN |
ITPKB |
Inositol-trisphosphate 3-kinase B |
6.354e-07 |
0.30
|
| PDE5A_HUMAN |
PDE5A |
cGMP-specific 3',5'-cyclic phosphodiesterase |
8.276e-07 |
0.38
|
| ADRB1_RAT |
Adrb1 |
Beta-1 adrenergic receptor |
1.534e-06 |
0.32
|
| CA2D1_RAT |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
1.574e-06 |
0.33
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
1.935e-06 |
0.30
|
| A0A059UE90_BOVIN |
GSK3beta |
Glycogen synthase kinase-3 beta splice variant X1 |
2.795e-06 |
0.32
|
| SC6A2_HUMAN |
SLC6A2 |
Sodium-dependent noradrenaline transporter |
3.14e-06 |
0.40
|
| NK3R_RAT |
Tacr3 |
Neuromedin-K receptor |
3.825e-06 |
0.29
|
| VMAT2_RAT |
Slc18a2 |
Synaptic vesicular amine transporter |
4.511e-06 |
0.31
|
| ACHP_LYMST |
|
Acetylcholine-binding protein |
4.784e-06 |
0.31
|
| CHIA_HUMAN |
CHIA |
Acidic mammalian chitinase |
5.649e-06 |
0.31
|
| O97467_PLAFA |
ht1 |
Hexose transporter 1 |
6.154e-06 |
0.38
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
6.358e-06 |
0.30
|
| DPOL_VACCW |
POL |
DNA polymerase |
6.502e-06 |
0.29
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
6.664e-06 |
0.33
|
| CACB1_RAT |
Cacnb1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
7.334e-06 |
0.33
|
| HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
8.871e-06 |
0.37
|